The Journal of Practical Medicine >

2020 , Vol. 36 >Issue 22: 3069 - 3073

DOI: https://doi.org/10.3969/j.issn.1006⁃5725.2020.22.008

Basic Research

Icariin Ⅱ inhibits epithelial⁃mesenchymal transition in tongue squamous cell carcinoma

Expand
  • Maxillofacial Plastic Surgery，Qinghai Provincial People′s Hospital，Xining 810008，China

Online published: 2020-12-14

Fold

Abstract

Objective To study the inhibitional effect of the icariin Ⅱ on epithelial⁃esenchymal transition（EMT）in tongue squamous cell carcinoma（TSCC）and explore its regulation through Notch1/PTEN/FAK signalingpathway. Methods Tca⁃8113 cells in logarithmic phase were randomly divided into blank group and ICSⅡlow，middle，high⁃dose groups. The comparisons were made among the groups in terms of cell proliferation inhibitionrate，cell migration，intervention ability，relative expression of Notch1，PTEN，FAK，p⁃FAK protein of eachgroup. Results The proliferation inhibition rate of ICSⅡ low，medium，high⁃dose groups showed an upward trendat 24，48 and 72 hours（P < 0.05）. The mobility and the number of transmembrane cells per field，Notch1 proteinrelative expression and p⁃FAK/FAK of the blank group，ICSⅡ low，medium，high⁃dose groups showed a down⁃ward trend（P < 0.05），of which the PTEN protein relative expression showed an increasing trend（P < 0.05）.Conclusion ICSⅡ can inhibit TSCC EMT in a dose⁃ependent manner，which is speculated to be related to thedown⁃regulation of Notch1 expression，up⁃regulation of PTEN expression，and inhibition of FAK phosphorylation.

Key words： icariin Ⅱ; tongue squamous cell carcinoma; inhibition; epithelial mesenchymal transi?tion; Notch1/PTEN/FAK signaling pathway

Cite this article

MO Zhiyang, LI Ying, HAN Xiaodong, WANG Hongxia, WENG Qiaofeng . Icariin Ⅱ inhibits epithelial⁃mesenchymal transition in tongue squamous cell carcinoma[J]. The Journal of Practical Medicine, 2020 , 36(22) : 3069 -3073 . DOI: 10.3969/j.issn.1006⁃5725.2020.22.008

Options
Outlines

/

〈 〉